Vision Impairment and Ban on Use of Avastin for Eye Diseases
Aims to #End Blindness Background Today, we are launching our campaign to raise awareness and express our concerns about the increasing spread of vision impairment and blindness. This troubling situation has developed due to the ban imposed by the Punjab caretaker government in September 2023 on an off-label drug, Avastin, which was previously used to treat eye diseases. This ban was enacted without providing a low-cost alternative for eye patients. Although the ban was later lifted, there was a lack of proper notification to doctors and hospitals, who reported not receiving any communication until the time of this report. Impact of the Ban Ophthalmologists had been using Avastin off-label because it was cost-effective and affordable for low-income patients. The cost of Avastin was approximately Rs. 1200 per dose per eye in government-run hospitals and Rs. 15,000 to Rs. 20,000 in private hospitals, including hospital charges. Other alternative drugs, such as Partiza, Eylea, and Lu...